Viewing Study NCT01103635


Ignite Creation Date: 2025-12-24 @ 10:12 PM
Ignite Modification Date: 2025-12-29 @ 8:02 PM
Study NCT ID: NCT01103635
Status: COMPLETED
Last Update Posted: 2020-04-07
First Post: 2010-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module